The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy

Netherlands Heart Journal

Volumn 17, Issue 12, 2009, Pages 481-486

  Olimulder, M A G M ^a   van Es, J ^a   Galjee, M A ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Cardiac magnetic resonance imaging; Cardiomyopathy; Myocarditis

Indexed keywords

EID: 77949597545     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/bf03086308     Document Type: Review

References (37)

1. Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: patho-genetic and clinical significance. Eur J Heart Fail. 2002;4: 411-7.
2. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006;113:593-5.
3. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001;104:1076-82.
4. Kadalie CT. [MRI in chronic myocarditis]. Z Kardiol. 2005; 94(Suppl 4):IV/94-IV/96.
5. Esfandiarei M, McManus BM. Molecular biology and patho-genesis of viral myocarditis. Annu Rev Pathol. 2008;3:127-55.
6. Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J. 2007;28:1326-33.
7. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, et al. Predictors of outcome in patients with suspected myocarditis. Circulation. 2008;118:639-48.
8. Skouri HN, Dec GW, Friedrich MG, Cooper LT. Noninvasive imaging in myocarditis. J Am Coll Cardiol. 2006;48:2085-93.
9. Lieberman EB, Herskowitz A, Rose NR, Baughman KL. A clinico-pathologic description of myocarditis. Clin Immunol Immuno-pathol. 1993;68:191-6.
10. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114: 1581-90.
11. McCarthy RE, III, Boehmer JP, Hruban RH, Hutchkins G.M, Kasper E.K, Hare J.M et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342:690-5.
12. Kodama M, Oda H, Okabe M, Aizawa Y, Izumi T. Early and long-term mortality of the clinical subtypes of myocarditis. Jpn Circ J. 2001;65:961-4.
13. De CF, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R, et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol. 2006;47:1649-54.
14. Gutberlet M, Spors B, Thoma T, Bertram H, Denecke T, Felix R, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology. 2008;246:401-9.
15. Zagrosek A, Wassmuth R, Abdel-Aty H, Rudolph A, Dietz R, Schulz-Menger J. Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis – a CMR study. J Cardiovasc Magn Reson. 2008; 10:19.
16. Kuhl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005;27;112: 1965-70.
17. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000; 343:1388-98.
18. Dennert R, Crijns HJ, Heymans S. Acute viral myocarditis. Eur Heart J. 2008;29:2073-82.
19. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation. 1999;99:1091-100.
20. Noutsias M, Pauschinger M, Kuhl U, Schultheiss HP. [Myo-carditis and dilated cardiomyopathy. New methods in diagnosis and therapy]. MMW Fortschr Med. 2002;144:36-40.
21. Spotnitz MD, Lesch M. Idiopathic dilated cardiomyopathy as a late complication of healed viral (Coxsackie B virus) myocarditis: historical analysis, review of the literature, and a postulated unifying hypothesis. Prog Cardiovasc Dis. 2006;49:42-57.
22. Caforio AL, Iliceto S. Genetically determined myocarditis: clinical presentation and immunological characteristics. Curr Opin Car-diol. 2008;23:219-26.
23. Shehata ML, Turkbey EB, Vogel-Claussen J, Bluemke DA. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies. Top Magn Reson Imaging. 2008;19:43-57.
24. Abdel-Aty H, Boye P, Zagrosek, Wassmuth R, Kumar A, Messroghli D, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005; 45:1815-22.
25. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiasdis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250-8.
26. Yelgec NS, Dymarkowski S, Ganame J, Bogaert J. Value of MRI in patients with a clinical suspicion of acute myocarditis. Eur Radiol. 2007;17:2211-7.
27. Bohl S, Wassmuth R, Abdel-Aty H, Rudolph A, Messroghli D, Dietz R, et al. Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging. 2008;24:597-607.
28. Deb K, Djavidani B, Buchner S, Poschenrieder F, Heinicke N, Feuerbach S, et al. Time course of eosinophilic myocarditis visual-ized by CMR. J Cardiovasc Magn Reson. 2008;10:21.
29. Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE. T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson Med. 2007;57:891-7.
30. Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, et al. Interferon-beta treatment eliminates cardio-tropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dys-function. Circulation 2003;107:2793-8.
31. McNamara DM, Rosenblum WD, Janosko KM, Trost MK, Villaneuva FS, Demetris AJ, et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation. 1997;95:2476-8.
32. Karatolios K, Pankuweit S, Maisch B. Diagnosis and treatment of myocarditis: the role of endomyocardial biopsy. Curr Treat Options Cardiovasc Med. 2007;9:473-81.
33. McNamara DM, Holubkov R, Starling RC, Dec GW, Mc Manus BM, Billingham ME, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation. 2001;103:2254-9.
34. Mason JW, O’Connell JB, Herskowitz A, Yang E, Mc Connell M.V. Berry C.J, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333:269-75.
35. Allanore Y, Vignaux O, Arnaud L, Puechal X, Pavy S, Dubo D, et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis. 2006;65:249-52.
36. Fenster BE, Chan FP, Valentine HA, Yang E, Mc Connell MV, Berry CJ, et al. Images in cardiovascular medicine. Cardiac magnetic resonance imaging for myocarditis: effective use in medical decision making. Circulation. 2006;113:e842-e843.
37. Dill T, Ekinci O, Hansel J, Kluge A, Breidenbach C, Hamm CW. Delayed contrast-enhanced magnetic resonance imaging for the detection of autoimmune myocarditis and long-term follow-up. J Cardiovasc Magn Reson. 2005;7:521-3.